Neuroprotective effect of L-serine against temporary cerebral ischemia in rats

Journal of Neuroscience Research

Volumn 88, Issue 9, 2010, Pages 2035-2045

  Wang, Guo Hua ^a   Jiang, Zheng Lin ^a   Chen, Zhao Qin ^a   Li, Xia ^a   Peng, Liang Liang ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

L serine; Neuroprotection; Temporary cerebral ischemia

Indexed keywords

CASPASE 3; GLUTAMIC ACID; LACTATE DEHYDROGENASE; SERINE; STRYCHNINE;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN NERVE CELL; BRAIN WATER; CELL DAMAGE; CELL LOSS; CELL VIABILITY; DRUG EFFECT; HIPPOCAMPUS; HYPOXIA; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL HYPOXIA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTAMIC ACID; GLYCINE AGENTS; HIPPOCAMPUS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SERINE; STRYCHNINE; TIME FACTORS;

EID: 77953517372     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22365     Document Type: Article

References (37)

1. Akaike N, Kaneda M. 1989. Glycine-gated chloride current in acutely isolated rat hypothalamic neurons. J Neurophysiol 62:1400-1409. (Pubitemid 20018094)
2. Baird AE, Warach S. 1998. Magnetic resonance imaging of acute stroke. J Cereb Blood Flow Metab 18:583-609. (Pubitemid 28262455)
3. Betz H. 1991. Glycine receptors: heterogeneous and widespread in the mammalian brain. Trends Neurosci 14:458-461.
4. Chen JL, Li Y, Wang L, Zhang ZG, Lu DY, Lu M, Chopp M. 2001. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32:1005-1011. (Pubitemid 32285175)
5. Cheng YD, Al-Khoury L, Zivin JA. 2004. Neuroprotection for ischemic stroke: two decades of success and failure. NeuroRx 1:36-45.
6. Cole DJ, Matsumura JS, Drummond JC, Schultz RL, Wong MH. 1991. Time- and pressure-dependent changes in blood-brain barrier permeability after temporary middle cerebral artery occlusion in rats. Act Neuropath 82:266-273.
7. Daly JW. 2005. Nicotinic agonists, antagonists, and modulators from natural sources. Cell Mol Neurobiol 25:513-552.
8. de Koning TJ, Snell K, Duran M, Berger R, Poll-The BT, Surtees R. 2003. L-serine in disease and development. Biochem J 371:653-661.
9. Furuya S, Tabata T, Mitoma J, Yamada K, Yamasaki M, Makino A, Yamamoto T, Watanabe M, Kano M, Hirabayashi Y. 2000. L-Serine and glycine serve as major astroglia-derived trophic factors for cerebellar Purkinje neurons. PNAS USA 97:11528-11533.
10. Garcia JH, Wagner S, Liu KF, Hu XJ. 1995. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Stroke 26:627-635.
11. Germano AF, Dixon CE, d'Avella D, Hayes RL, Tomasello F. 1994. Behavioral deficits following experimental subarachnoid hemorrhage in the rat. J Neurotrauma 11:345-353.
12. Gerriets T, Li F, Silva MD, Meng X, Brevard M, Sotak CH, Fisher M. 2003. The macrosphere model: evaluation of a new stroke model for permanent middle cerebral artery occlusion in rats. J Neurosci Methods 122:201-211.
13. Green AR. 2008. Pharmacological approaches to acute ischaemic stroke: reperfusion certainly, neuroprotection possibly. Br J Pharm 153:S325-S338.
14. Hashimoto A. 2002. Effect of the intracerebroventricular and systemic administration of L-serine on the concentrations of D- and L-serine in several brain areas and periphery of rat. Brain Res 955:214-220.
15. Hazell AS. 2007. Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int 50:941-953.
16. Heiland S, Benner T, Reith W, Forsting M, Sartor K. 1997. Perfusion-weighted MRI using gadobutrol as a contrast agent in a rat stroke model. J Magn Reson Imaging 7:1109-1115.
17. Jiang ZL, Krnjević K, Wang FS, Ye JH. 2004. Taurine activates strychnine-sensitive glycine receptors in neurons freshly isolated from nucleus accumbens of young rats. J Neurophysiol 91:248-257.
18. Jonas S, Aiyagari V, Vieira D, Figueroa M. 2001. The failure of neuronal protective agents versus the success of thrombolysis in the treatment of ischemic stroke. The predictive value of animal models. Ann NY Acad Sci 939:257-267.
19. Joshi CN, Jain SK, Murthy PS. 2004. An optimized triphenyltetrazolium chloride method for identification of cerebral infarcts. Brain Res Brain Res Protoc 13:11-17.
20. Legendre P. 2001. The glycinergic inhibitory synapse. Cell Mol Life Sci 58:760-793.
21. Liu FD, Schafer DP, McCullough LD. 2009. TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosci Methods 179:1-8.
22. Loubinoux I, Volk A, Borredon J, Guirimand S, Tiffon B, Seylaz J, Méric P. 1997. Spreading of vasogenic edema and cytotoxic edema assessed by quantitative diffusion and T2 magnetic resonance imaging. Stroke 28:419-427. (Pubitemid 27097015)
23. McCool BA, Botting SK. 2000. Characterization of strychnine-sensitive glycine receptors in acutely isolated adult rat basolateral amygdala neurons. Brain Res 859:341-351.
24. Mitoma J, Furuya S, Hirabayashi Y. 1998. A novel metabolic communication between neurons and astrocytes: non-essential amino acid L-serine released by astrocytes is essential for developing hippocampal neurons. Neurosci Res 30:195-199.
25. Mothet JP, Parent AT, Wolosker H, Brady RO Jr., Linden DJ, Ferris CD, Rogawski MA, Snyder SH. 2000. D-Serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor. PNAS USA 97:4926-4931.
26. Nguelefack TB, Nana P, Atsamo AD, Dimo T, Watcho P, Dongmo AB, Tapondjou LA, Njamen D, Wansi SL, Kamanyi A. 2006. Analgesic and anticonvulsant effects of extracts from the leaves of Kalanchoe crenata (Andrews) Haworth (Crassulaceae). J Ethnopharmacol 106:70-75.
27. Oda M, Kure S, Sugawara T, Yamaguchi S, Kojima K, Shinka T, Sato K, Narisawa A, Aoki Y, Matsubara Y, Omae T, Mizoi K, Kinouchi H. 2007. Direct correlation between ischemic injury and extracellular glycine concentration in mice with genetically altered activities of the glycine cleavage multienzyme system. Stroke 38:2157-2164.
28. Oliet SH, Mothet JP. 2009. Regulation of N-methyl-D-aspartate receptors by astrocytic D-serine. Neuroscience 158:275-283.
29. Phillis JW, O'Regan MH. 2003. Characterization of modes of release of amino acids in the ischemic/reperfused rat cerebral cortex. Neurochem Int 43:461-467.
30. Rampon C, Luppi PH, Fort P, Peyron C, Jouvet M. 1996. Distribution of glycine-immunoreactive cell bodies and fibers in the rat brain. Neuroscience 75:737-755.
31. Smith QR, Momma S, Aoyagi M, Rapoport SI. 1987. Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49:1651-1658.
32. Szatkowski M, Attwell D. 1994. Triggering and execution of neuronal death in brain ischemia: two phases of glutamate release by different mechanisms. Trends Neurosci 17:359-365.
33. Trailović SM, Varagić VM. 2007. The effect of ivermectin on convulsions in rats produced by lidocaine and strychnine. Vet Res Comm 31:863-872.
34. A and glycine receptors. Neuropharmacology 52:1199-1209.
35. Wolosker H, Blackshaw S, Snyder SH. 1999. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. PNAS USA 96:13409-13414.
36. Yang GY, Betz AL. 1994. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke 25:1658-1665. (Pubitemid 24233975)
37. Yasuda E, Ma N, Semba R. 2001. Immunohistochemical demonstration of L-serine distribution in the rat brain. Neuroreport 12:1027-1030. (Pubitemid 32281468)